Combined KRAS <sup>G12C</sup> and SOS1 inhibition enhances and extends the anti-tumor response in KRAS <sup>G12C</sup> -driven cancers by addressing intrinsic and acquired resistance

Venu Thatikonda(BioScientia (Poland)), Marco H. Hofmann(Boehringer Ingelheim (Austria))

bioRxiv (Cold Spring Harbor Laboratory)

January 23, 2023

10.1101/2023.01.23.525210

Cited by 17

Related Papers

A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells

|Molecular Cancer Research|2009|56

Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

|Nature Cancer|2024|45